|
A Population Pharmacokinetic Model and Dosing Algorithm to Guide the Tacrolimus Starting and Follow-Up Dose in Living and Deceased Donor Kidney Transplant Recipients.
|
Francke MI, Sassen SDT, Lloberas N, Colom H, Elens L, Moudio S, de Vries APJ, Moes DJAR, van Schaik RHN, Hesselink DA, de Winter BCM
|
40588615
|
01-09-2025
|
04-05-2026
|
|
|
Changes in quality of vitamin K antagonist treatment and clinical outcomes during Ramadan: a Dutch population-based cohort study.
|
Kempers EK, Chen Q, van Rein N, Atiq F, Schindhelm RK, Wiersma NM, Dronkers CEA, Beinema M, Ten Cate-Hoek AJ, Nierman MC, Stork ADM, Moriarty P, Klok FA, Cannegieter SC, Kruip MJHA
|
40988731
|
13-08-2025
|
16-04-2026
|
|
|
Semaglutide impairs bioavailability of alectinib: a note of warning based on a cross-over pharmacokinetic drug-drug interaction study.
|
Heersche N, Lanser DAC, Oomen-de Hoop E, Içli A, de Bruijn P, Paats MS, van Rossum EFC, Koolen SLW, van Schaik RHN, Dingemans AC, Veerman GDM, Mathijssen RHJ
|
40308149
|
01-08-2025
|
04-05-2026
|
|
|
Pharmacokinetics of betamethasone in pre-eclampsia: An in vivo and ex vivo study.
|
Schoenmakers S, Li L, Kluivers ACM, Broekhuizen M, Harhangi MS, Danser AHJ, Reiss I, Allegaert K, van den Berg SAA, van Zelst BD, van Schaik RHN, DeKoninck PLJ, Ronde E, Sassen SDT, Simons SHP, Koch BCP
|
40083164
|
01-08-2025
|
04-05-2026
|
|
|
Recommendations for (Pharmaco)Genetic Sampling in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation.
|
Bokma A, Matic M, Ralf A, van den Bosch BJC, Kayser M, van Schaik RHN, Lafeber M, Coenen MJH, Atrafi F
|
40802525
|
01-08-2025
|
04-05-2026
|
|
|
Daily blood flow restriction does not preserve muscle mass and strength during 2 weeks of bed rest.
|
Fuchs CJ, Hermans WJH, Nyakayiru J, Weijzen MEG, Smeets JSJ, Aussieker T, Senden JM, Wodzig WKHW, Snijders T, Verdijk LB, van Loon LJC
|
38411283
|
01-07-2025
|
14-04-2026
|
|
|
Dose-individualisation of fluoropyrimidines based on pre-treatment serum uracil levels: the Alpe2U study.
|
Knikman JE, de With M, Heersche N, Lopez-Yurda M, Baars A, Creemers GJ, Droogendijk HJ, Fiets E, Imholz ALT, Iersel LV, Mandigers CMPW, van de Vendel AJ, Jeurissen FJF, Nieboer P, Deenen MJ, van de Poel MHW, Wymenga MNM, van Schaik RHN, van den Bosch BJC, Hoop EO, Rosing H, Swen JJ, Gelderblom H, Schellens JHM, Beijnen JH, Mathijssen RHJ, Guchelaar HJ, Cats A
|
40466468
|
25-06-2025
|
04-05-2026
|
|
|
Relationship Between Exercise-Induced Cardiac Troponin Elevations and Occult Coronary Atherosclerosis in Middle-Aged Athletes.
|
Janssen SLJE, van Everdingen WM, Saalmink WBJ, Lamers SK, Vroemen WHM, Denessen EJS, Berge K, Bekers O, Hopman MTE, Brink M, Habets J, Aengevaeren VL, Mingels AMA, Nijveldt R, Eijsvogels TMH, TREAT study collaboration
|
40533126
|
24-06-2025
|
07-04-2026
|
|
|
ADRB2 genotype-guided treatment for childhood asthma: Cost analysis of the PUFFIN and PACT trials.
|
Slob EMA, Frederix GWJ, Vijverberg SJH, Noij LCE, Ruffles T, Vasbinder EC, Mukhopadhyay S, van Schaik RHN, Kersten ETG, Pijnenburg MW, Koppelman GH, Maitland-van der Zee AH, PUFFIN and PACT investigators
|
40464075
|
01-06-2025
|
04-05-2026
|
|
|
Cost-effectiveness of implementing a genotype-guided de-escalation strategy in patients with acute coronary syndrome.
|
van den Broek WWA, Azzahhafi J, Chan Pin Yin DRPP, van der Sangen NMR, Sivanesan S, Dijksman LM, Walhout RJ, Tjon Joe Gin M, Breet NJ, Langerveld J, Vlachojannis GJ, van Bommel RJ, Appelman Y, van Schaik RHN, Henriques JPS, Kikkert WJ, Ten Berg JM
|
39537191
|
02-05-2025
|
04-05-2026
|
|
|
Sex and Common Germline Variants Affect the Toxicity Profile and Pharmacokinetics of Alectinib: A Nationwide Cohort Study in Patients With ALK-Positive NSCLC.
|
Heersche N, Lanser DAC, Muntinghe-Wagenaar MB, Mohmaed Ali MI, Ulas EB, Trooster TMA, de Jonge E, Oomen-de Hoop E, Paats MS, Bahce I, Croes S, Hendriks LEL, van der Wekken AJ, Dingemans AC, Huitema ADR, van Schaik RHN, Mathijssen RHJ, Veerman GDM
|
39617342
|
01-04-2025
|
04-05-2026
|
|
|
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between SLCO1B1 and statins and CYP2C9 and sulfonylureas.
|
Wolthuis DFGJ, Nijenhuis M, Soree B, de Boer-Veger NJ, Buunk AM, Guchelaar HJ, Risselada A, Rongen GAPJM, van Schaik RHN, Swen JJ, Touw DJ, van Westrhenen R, Deneer VHM, Houwink EJF
|
39676086
|
01-04-2025
|
04-05-2026
|
|
|
Genotype-Guided Asthma Treatment Reduces Exacerbations in Children: Meta-Analysis of Two Randomized Control Trials.
|
Slob EMA, Vijverberg SJH, Ruffles T, Noij LCE, Biermann J, Brouwer AFJ, van den Brink K, de Bruin-Kok A, Van Ewijk BE, Haarman E, Hammer SC, Hashimoto S, Hogarth F, Jones CJ, Kamps AWA, Kersten ETG, de Kleer I, Lipworth BJ, Littleford R, Mérelle M, Moeller A, Palmer CNA, Pilvinyte K, Rutjes NW, van Schaik RHN, Smith HE, Tavendale R, Terheggen-Lagro SWJ, Turner S, Twisk JWR, Vaessen-Verberne A, Verwaal M, de Vries T, Wesseling J, Pijnenburg MW, Koppelman GH, Mukhopadhyay S, Maitland-van der Zee AH
|
39723595
|
01-04-2025
|
04-05-2026
|
|
|
Clinical ischemia-reperfusion injury: Driven by reductive rather than oxidative stress? A narrative review.
|
de Kok MJC, Schaapherder AFM, Bloeme-Ter Horst JR, Faro MLL, de Vries DK, Ploeg RJ, Bakker JA, Lindeman JHN
|
39828238
|
01-04-2025
|
09-04-2026
|
|
|
Severe fluoropyrimidine toxicity in older adults with cancer with DPYD wild type.
|
Brokaar E, Knikman J, Visser L, van den Bos F, Henricks L, Lunenburg C, de Man F, Gelderblom H, Schellens J, Mathijssen R, Guchelaar HJ, Portielje J, Cats A, Postmus W, de Glas N
|
39969252
|
01-04-2025
|
06-05-2026
|
|
|
The Pharmacogenomics Global Research Network Implementation Working Group: global collaboration to advance pharmacogenetic implementation.
|
Cavallari LH, Hicks JK, Patel JN, Elchynski AL, Smith DM, Bargal SA, Fleck A, Aquilante CL, Killam SR, Lemke L, Ochi T, Ramsey LB, Haidar CE, Ho T, El Rouby N, Monte AA, Allen JD, Beitelshees AL, Bishop JR, Bousman C, Campbell R, Cicali EJ, Cook KJ, Duong B, Tsermpini EE, Girdwood ST, Gregornik DB, Grimsrud KN, Lamb N, Lee JC, Lopez RO, Mazhindu TA, Morris SA, Nagy M, Nguyen J, Pasternak AL, Petry N, van Schaik RHN, Schultz A, Skaar TC, Al Alshaykh H, Stevenson JM, Stone RM, Tran NK, Tuteja S, Woodahl EL, Yuan LC, Lee CR
|
39485373
|
01-01-2025
|
04-05-2026
|
|
|
International normalized ratio measurement during perioperative anticoagulation bridging with low-molecular-weight heparin in patients undergoing heart valve replacement surgery.
|
Rijvers L, Rijpma SR, van Wetten HB, Henskens YMC, Stroobants AK
|
39687922
|
05-11-2024
|
16-04-2026
|
|
|
Clinical Decision-Making Suffers from Inequivalent Measurement Results and Inadequate Reference Intervals.
|
van Schrojenstein Lantman M, van Berkel M, Kuijper P, Langelaan M, Brouwer N, Thelen M
|
39288014
|
04-11-2024
|
16-04-2026
|
|
|
Evidence for stability of cardiac troponin T concentrations measured with a high sensitivity TnT test in serum and lithium heparin plasma after six-year storage at -80 °C and multiple freeze-thaw cycles.
|
Henricks LM, Romijn FPHTM, Cobbaert CM
|
39479776
|
31-10-2024
|
06-05-2026
|
|
|
Differences in Cardiac Troponin T Composition in Myocardial Infarction and End-Stage Renal Disease Patients: A Blood Tube Effect?
|
Vroemen WHM, Denessen EJS, van Doorn WPTM, Pelzer KEJM, Hackeng TM, Litjens EJR, Henskens YMC, van der Sande FM, Wodzig WKWH, Kooman JP, Bekers O, de Boer D, Mingels AMA
|
38816928
|
03-09-2024
|
13-04-2026
|
|
|
Discovering novel germline genetic variants linked to severe fluoropyrimidine-related toxicity in- and outside DPYD.
|
Knikman JE, Zhai Q, Lunenburg CATC, Henricks LM, Böhringer S, van der Lee M, de Man FM, Offer SM, Shrestha S, Creemers GJ, Baars A, Dezentjé VO, Imholz ALT, Jeurissen FJF, Portielje JEA, Jansen RLH, Hamberg P, Droogendijk HJ, Koopman M, Nieboer P, van de Poel MHW, Mandigers CMPW, van Schaik RHN, Gelderblom H, Mathijssen RHJ, Schellens JHM, Cats A, Guchelaar HJ, Swen JJ
|
39148102
|
15-08-2024
|
06-05-2026
|
|
|
A Low or High Physical Activity Level Does Not Modulate Prostate Tumor Tissue Protein Synthesis Rates.
|
Houben LHP, Tuytten T, Holwerda AM, Wisanto E, Senden J, Wodzig WKWH, Olde Damink SWM, Beelen M, Beijer S, VAN Renterghem K, VAN Loon LJC
|
38079310
|
01-04-2024
|
14-04-2026
|
|
|
Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung Disease.
|
Drent M, Wijnen PA, Jessurun NT, Harmsze AM, Bekers O, Bast A
|
38460070
|
01-04-2024
|
07-04-2026
|
|
|
Administration of Free Amino Acids Improves Exogenous Amino Acid Availability when Compared with Intact Protein in Critically Ill Patients: A Randomized Controlled Study.
|
van Gassel RJ, Weijzen ME, Kouw IW, Senden JM, Wodzig WK, Olde Damink SW, van de Poll MC, van Loon LJ
|
38103646
|
01-02-2024
|
14-04-2026
|
|
|
[Critical results reporting: the importance of local partnership agreements].
|
Schindhelm RK
|
38319305
|
09-01-2024
|
16-04-2026
|
|
